Merck Joins Messenger RNA Frenzy, Betting $100M on Moderna Therapeutics

Facebook
ВКонтакте
share_fav

Generations of scientists have known that messenger RNA plays a key role in carrying genetic information in cells, but thought the molecules themselves could never be drugs. Merck, the pharmaceutical giant, just bet they can become drugs after all. Moderna Therapeutics, the Cambridge, Mass.-based company that has taken the biotech industry by [...]

посмотреть на Forbes